Long-term survivors with extensive-stage small-cell lung cancer treated with first-line durvalumab plus carboplatin and etoposide: The CANTABRICO trial
Por:
Casado M, Aperribay E, Campelo M, Blanco C, Tain P, Piqueras M, Vega A, Mateos L, Rodriguez J, Calderon V, Majem M, Hernandez A, de la Rosa C, Cabellos R, Sureda B, Baret M, Martos J, Dominguez M, Paz-Ares L
Publicada:
1 mar 2025
Resumen:
|